All News
Dr. van der Heijde presents results of dual neutralization of Il-17A and F with bimekizumab which may provide a new therapeutic option for patients with AxSpA. Abstract OPO231. #EULAR2019 @RheumNow #spondylitis https://t.co/caOkc47jyn
Hillary Norton DrHillaryNorton ( View Tweet)
Dr. Xenofon Baraliakos presents the MAXIMISE trial which showed improvement in axial involvement in PsA patients treated with secukinumab. Abstract OPO235 #EULAR2019 @RheumNow #spondylitis #Novartis https://t.co/exxbgIxgJT
Hillary Norton DrHillaryNorton ( View Tweet)
Ciurea, Switzerland: no clear benefit of switching to IL-17i rather than another TNFi after failed TNFi in #axial #spondyloarthritis... might even be trend to reduced outcomes in men.
Nice example of real-world data challenging largely “evidence-free” dogma
#EULAR2019 @RheumNow
Stefan Siebert StefanSiebert1 ( View Tweet)
No increase in immunogenicity after switching (1 or more) from originator IFX to biosimilars in pts with #RheumatoidArthritis according to a prospective study by Lauret et al. #EULAR2019 @RheumNow #Rheumatology https://t.co/SB89O1Kdc2
Sebastian C Rodriguez-García sdlcrodriguez ( View Tweet)
GCA patients have decreased proportions of PD1+CD4+ Th cells compared to normal controls, building on previous Weyand lab work. Once again, irAEs and PMR/GCA might be friends? #EULAR2019 FRI0266 Hid Cadena from Elisabeth Brouwer’s group @RheumNow https://t.co/H6bhO1jH2S
David Liew drdavidliew ( View Tweet)
Mayo RCT on Flares in established RA randomized 150 pts to usual care or a flare (pt self declared) survey scheme found pts flaring prefer self management 62% over expedited clinic visit 32%, but intervention was no better than usual care! OP0309 #Eular2019 https://t.co/zGlW43ppqi
Dr. John Cush RheumNow ( View Tweet)
Beautifully presented abstract on protective effect of LLDAS independent of baseline disease activity&damage status. Protection is higher in pts with active disease (SLEDAI >=6) and those already had damage accrual (SDI>=1). #eular2019 #aplc @EricFMorand @Monash_FMNHS @RheumNow
Alberta Hoi tuna0sashimi ( View Tweet)
Performance of ACR CRISS in different recent trials. Superior to mRSS.#EULAR2019. @RheumNow https://t.co/giQEiFd0Uv
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
Central and peripheral site readers of SI joint MRIs - how do they fare in the nr-axSpA era? #EULAR2019 THU0359 from ASAS @RheumNow https://t.co/9RI22Gb7jx
David Liew drdavidliew ( View Tweet)
Clinical practice-friendly VAS assessIng different aspects of Rheum diseases: physicians rated #gout inflammation, damage, and global scores as high/higher than RA. Dr Nika discusses. Let’s have high levels of gout treat-to-target strategy discussions too! @RheumNow #EULAR2019 https://t.co/wMf7yR2GPA
Gout Study Group GoutGroup ( View Tweet)
Does age of onset of Sjögren's syndrome change % with sicca symptoms (dry eyes & mouth)? #EULAR2019 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
a few presentations from RISE-SSc at #EULAR2019. @BayerPharma @RheumNow 1. Riociguat has a beneficial impact on FVC. More data to support anti fibrotic role in early scleroderma ILD https://t.co/77SP2qU7SH
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
bilateral or unilateral knee inflammatory arthritis fully resolves in 60% at 1 yr. 10% spread. THU0674 #EULAR2019 @RheumNow https://t.co/lCjQ1aAvNz
Janet Pope Janetbirdope ( View Tweet)
OPO315 ERA cohort shows fatigue improvement lags behind remission by 6 months. #EULAR2019 @RheumNow https://t.co/6toBquAy2Q
Janet Pope Janetbirdope ( View Tweet)
Calcific rotator cuff tendonitis is usually treated with steroid injections and only 10% need surgery THU0504 #EULAR2019 @RheumNow https://t.co/VHBGJ36MlL
Janet Pope Janetbirdope ( View Tweet)
Initial prescription of #tramadol associated with > mortality vs #nsaids over 1 year follow up #EULAR2019 https://t.co/moBAohdkBx
Evan Vista, MD evanvistamd ( View Tweet)
Riociquat in Scleroderma ILD. Almost worked on skin, but did work in those with ILD. OP0183 #EULAR2019 https://t.co/ySHQxOCrb5
Links:
Dr. John Cush RheumNow ( View Tweet)
I hate the term “appropriate.” It’s meaningless or stands as a flag for moral/social/radical and cultural prejudice. Same with “rude.” So interpret it however you want.
Medical Axioms medicalaxioms ( View Tweet)
Six weeks of low-dose prednisolone improved #Pain and function in hand #osteoarthritis according to data presented at #EULAR19 https://t.co/SKndJfojFw
Healio Rheumatology HealioRheum ( View Tweet)
2019 EULAR/ACR #lupus #classification #criteria
#EULAR19 https://t.co/PzuFUNgCs5
dr hanady manasfi hanadymanasfi ( View Tweet)